CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2017. The put-call ratio across all filers is 15.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,355,000 | -14.5% | 119,147 | -18.1% | 0.11% | -23.4% |
| Q1 2019 | $13,273,000 | -1.4% | 145,462 | -18.0% | 0.14% | -19.0% |
| Q4 2018 | $13,464,000 | -39.4% | 177,365 | -36.2% | 0.18% | -29.5% |
| Q3 2018 | $22,233,000 | -21.7% | 277,915 | -2.8% | 0.25% | -25.7% |
| Q2 2018 | $28,394,000 | +20.0% | 285,859 | -2.2% | 0.34% | +11.8% |
| Q1 2018 | $23,669,000 | +31.6% | 292,216 | +28.0% | 0.31% | +28.0% |
| Q4 2017 | $17,989,000 | +41.8% | 228,373 | +66.1% | 0.24% | +39.0% |
| Q3 2017 | $12,685,000 | – | 137,482 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kite Lake Capital Management (UK) LLP | 207,382 | $24,135,000 | 76.46% |
| Maso Capital Partners Ltd | 539,597 | $62,798,000 | 20.20% |
| York Capital Management Global Advisors, LLC | 1,102,163 | $128,270,000 | 7.40% |
| HHLR ADVISORS, LTD. | 2,751,200 | $320,185,000 | 3.99% |
| Dalton Investments, Inc. | 15,551 | $1,810,000 | 1.14% |
| Athos Capital Ltd | 8,290 | $965,000 | 0.96% |
| Myriad Asset Management Ltd. | 67,019 | $7,799,000 | 0.94% |
| Temasek Holdings (Private) Ltd | 990,000 | $115,216,000 | 0.75% |
| OXFORD ASSET MANAGEMENT LLP | 211,646 | $24,631,000 | 0.68% |
| AGF Investments America Inc. | 12,230 | $1,423,000 | 0.47% |